Among the 59 elutriated PBMC concentrates, 28 were from men with stage 0 prostate cancer whose only measure of disease was a rising Prostate Specific Antigen (PSA) (biochemical recurrence) and the other 31 products were from patients with either multiple myeloma or various advanced solid cancers. Here, KLK3 is linked to AL amyloidosis.